Oncology PracticeNew toxicity subscale measures QOL in cancer patients on checkpoint inhibitorsJanuary 11, 2020ImmunotherapyLung CancerMelanomaCellular Therapy
Hematology NewsCAR T cells produce complete responses in T-cell malignanciesJanuary 7, 2020ALLT Cell LymphomasCellular TherapyLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersImmunotherapyImmuno-oncology
Hematology NewsCAR T-cell therapy advances in CLLDecember 26, 2019CLLCellular TherapyB Cell LymphomaLeukemia, Myelodysplasia, TransplantationImmuno-oncologyImmunotherapy
Hematology NewsInhibitor appears to strengthen anti-BCMA CAR T cells in myeloma patientsDecember 23, 2019Multiple MyelomaImmunotherapyLymphoma & Plasma Cell DisordersCellular TherapyImmuno-oncology
Hematology News‘Real-world’ data show CAR T therapies are cost effectiveDecember 13, 2019Business of MedicineCellular TherapyImmuno-oncologyImmunotherapyPractice Management
Hematology NewsAn off-the-shelf drug to rival CAR T cells: ‘very exciting’December 13, 2019B Cell LymphomaCellular TherapyLymphoma & Plasma Cell DisordersImmuno-oncologyImmunotherapy
Hematology NewsPT-Cy bests conventional GVHD prophylaxisDecember 10, 2019TransplantationPatient & Survivor CareCellular Therapy
Hematology NewsOff-the-shelf cellular therapy shows promise in the labDecember 8, 2019B Cell LymphomaCLLCellular TherapyImmuno-oncologyImmunotherapy
Hematology NewsBispecific CAR T-cells yield high response rate in relapsed/refractory myelomaDecember 7, 2019Multiple MyelomaCellular TherapyImmuno-oncologyImmunotherapyLymphoma & Plasma Cell Disorders
Hematology NewsHigh complete response rate seen with novel CAR-T for myelomaDecember 7, 2019Multiple MyelomaCellular TherapyImmuno-oncologyImmunotherapyLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsASH preview: Key themes include tackling CAR T obstacles, sickle cell advances, VTENovember 26, 2019Cellular TherapyALLMultiple MyelomaLymphoma & Plasma Cell DisordersImmuno-oncologyImmunotherapy
Hematology NewsWill TP53-mutated AML respond to immunotherapy?November 18, 2019AMLLeukemia, Myelodysplasia, TransplantationImmunotherapyCellular TherapyTranslational ResearchRare Diseases
Hematology NewsCAR T-cell ‘cocktail’ may overcome antigen escape relapseNovember 18, 2019B Cell LymphomaImmunotherapyLymphoma & Plasma Cell DisordersALLCellular Therapy
Hematology NewsArmored CAR T cells elicit responses in NHL patientsNovember 12, 2019B Cell LymphomaDLBCLLymphoma & Plasma Cell DisordersFollicular LymphomaImmunotherapyCellular TherapyImmuno-oncology
Hematology NewsImmunotherapies under investigation in newly diagnosed B-ALLOctober 1, 2019ALLLeukemia, Myelodysplasia, TransplantationImmunotherapyImmuno-oncologyCellular Therapy
